"Fortunate are those who take the first steps"? The psychosocial impact of novel drug development.
File(s)
Accepted version
Author(s)
Type
Journal Article
Abstract
Novel drug development offers people with cystic fibrosis exciting opportunities but is not without challenges. Currently, there is an understandable emphasis on protecting patients' physical health when developing treatments. However, there appears to be little consideration of how novel drug development impacts on psychosocial wellbeing, or the downstream consequences of this. Using an illustrative case and reviewing the literature we explore themes regarding the psychosocial impact of trial participation and novel drug development and identify areas requiring further research. Through this, we hope to prepare healthcare professionals to better understand the needs of their patients in this rapidly evolving landscape.
Date Issued
2019-08
Date Acceptance
2019-02-20
Citation
Paediatric Respiratory Reviews, 2019, 31, pp.9-11
ISSN
1526-0542
Publisher
Elsevier
Start Page
9
End Page
11
Journal / Book Title
Paediatric Respiratory Reviews
Volume
31
Copyright Statement
© 2019 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/30975518
PII: S1526-0542(19)30019-3
Grant Number
6586/6560
Subjects
Clinical research
Clinical trials
Drug development
Psychosocial impact
Publication Status
Published
Coverage Spatial
England
Date Publish Online
2019-02-27